The Feldenkrais Method for People With Intellectual Disability

Status Completed

Clinical Trial Summary

Loss of functioning and age-related health problems tend to appear earlier in individuals with intellectual disability (ID) than in their non-disabled peers and due to this people with ID who are in employment tend to need to retire earlier, producing social, economic and health problems. The Feldenkrais method (FM) is a movement-based form of learning that enhances body balance and physical functioning. We hypothesized that the FM could be helpful to improve balance and functioning of employed people with ID.

Clinical Trial Description

The aim of this study will be to determine the effects of a Feldenkraisn Method (FM) program in improving functionality and body balance in supported employed individuals with ID. To evaluate this effect, a total of subjects will participate in a longitudinal and clinical trial.

Sample size has been calculated to detect minimal significant effects on the variable of physical performance (SPPB): accepting an alpha risk of 0.05 and a beta risk of 0.20 in a bilateral contrast, 26 individuals are required in order to detect a difference equal to or greater than 1.5 unit in the SPPB (SD= 1.94). It has been increased the sample size in an additional 20% (losts during follow-up) and 5% (mortality). The resultant sample size is determinate in 32 individuals, who are equally randomized in both experimental and control groups.

Statistical analysis was performed using IBM SPSS Statistics for Windows (Version 22.0). Data were presented as mean ± standard deviation. Descriptive statistics were calculated for all outcome measures. Mean differences within the groups in the functional tests and stabilometric outcomes were estimated using paired sample t-tests, while mean differences between the groups in these variables were estimated using repeated measures analysis of variance. Differences were considered significant at p < 0.05. To determine the magnitude of the interactions between time and group, the effect size or µ2 was calculated as described by Cohen (1998) and interpreted as small (> 0.01 and < 0.06), moderate (≥ 0.06 and < 0.14) or large (≥ 0.14). ;

Study Design

Related Conditions & MeSH terms

Intellectual Disability

Clinical Trial Details

NCT number	NCT03203226
Study type	Interventional
Source	Basque Country University
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2016
Completion date	January 30, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05935722` - Evaluation of a Home-based Parenting Support Program: Parenting Young Children	N/A
Completed	`NCT04020302` - Self-Monitoring Shopping Intervention	N/A
Active, not recruiting	`NCT03548779` - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2	N/A
Completed	`NCT03722212` - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test	N/A
Not yet recruiting	`NCT03644797` - Second Molecular Event Identification by Exome Sequencing for Intellectually Disabled Patients Carrying 16p13.11 CNVs
Completed	`NCT03139760` - POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability	N/A
Not yet recruiting	`NCT02881333` - Various Type of Genetic Events in Patients With Intellectual Disability	N/A
Completed	`NCT02746614` - Psychomotor Therapy Effects in Adaptive Behavior and Motor Proficiency in Intellectual Disability	N/A
Completed	`NCT06097819` - Therapy-Based Games' Effects on Motor and Cognitive Skills in Intellectual Disabilities	N/A
Recruiting	`NCT05767203` - Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin	N/A
Terminated	`NCT05445596` - Improving Treatment for Children With Intellectual and Developmental Disabilities and Problem Behavior in Schools	N/A
Recruiting	`NCT05131425` - Facing Your Fears: Adolescents With ASD and Intellectual Disability	N/A
Completed	`NCT04436692` - Dietary Intervention and Adults With Intellectual Disabilities	N/A
Completed	`NCT04518358` - Expert Guiding Technology to Help Individuals With Developmental Challenges Build Life and Vocational Skills	N/A
Completed	`NCT04917666` - Process and Outcomes of Horticultural Therapy for People With Disabilities	N/A
Completed	`NCT04554355` - Effects of a PA Intervention for Fatness and Fitness in Adolescents With Intellectual Disability	N/A
Completed	`NCT04277130` - Effectiveness of Active Video Games in Children With Intellectual Disabilities	N/A
Enrolling by invitation	`NCT02914951` - Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability	N/A
Completed	`NCT03989388` - Occupational Self-Analysis Programme	N/A
Completed	`NCT02304302` - Down Syndrome Memantine Follow-up Study	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.